Literature DB >> 16514241

Quantification of the power of Hardy-Weinberg equilibrium testing to detect genotyping error.

David G Cox1, Peter Kraft.   

Abstract

Deviation from Hardy-Weinberg equilibrium has become an accepted test for genotyping error. While it is generally considered that testing departures from Hardy-Weinberg equilibrium to detect genotyping error is not sensitive, little has been done to quantify this sensitivity. Therefore, we have examined various models of genotyping error, including error caused by neighboring SNPs that degrade the performance of genotyping assays. We then calculated the power of chi-square goodness-of-fit tests for deviation from Hardy-Weinberg equilibrium to detect such error. We have also examined the affects of neighboring SNPs on risk estimates in the setting of case-control association studies. We modeled the power of departure from Hardy-Weinberg equilibrium as a test to detect genotyping error and quantified the effect of genotyping error on disease risk estimates. Generally, genotyping error does not generate sufficient deviation from Hardy-Weinberg equilibrium to be detected. As expected, genotyping error due to neighboring SNPs attenuates risk estimates, often drastically. For the moment, the most widely accepted method of detecting genotyping error is to confirm genotypes by sequencing and/or genotyping via a separate method. While these methods are fairly reliable, they are also costly and time consuming.

Mesh:

Year:  2006        PMID: 16514241     DOI: 10.1159/000091787

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  26 in total

1.  The number of markers in the HapMap project: some notes on chi-square and exact tests for Hardy-Weinberg equilibrium.

Authors:  Jan Graffelman
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

2.  A quality control algorithm for filtering SNPs in genome-wide association studies.

Authors:  Monnat Pongpanich; Patrick F Sullivan; Jung-Ying Tzeng
Journal:  Bioinformatics       Date:  2010-05-25       Impact factor: 6.937

Review 3.  Genome-wide association studies--data generation, storage, interpretation, and bioinformatics.

Authors:  Guillaume Pare
Journal:  J Cardiovasc Transl Res       Date:  2010-04-08       Impact factor: 4.132

4.  Optimal two-stage design for case-control association analysis incorporating genotyping errors.

Authors:  Y Zuo; G Zou; J Wang; H Zhao; H Liang
Journal:  Ann Hum Genet       Date:  2008-01-23       Impact factor: 1.670

5.  Using both cases and controls for testing hardy-weinberg proportions in a genetic association study.

Authors:  Jian Wang; Sanjay Shete
Journal:  Hum Hered       Date:  2010-03-05       Impact factor: 0.444

6.  Approximate and exact tests of Hardy-Weinberg equilibrium using uncertain genotypes.

Authors:  Daniel Shriner
Journal:  Genet Epidemiol       Date:  2011-09-15       Impact factor: 2.135

7.  Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects.

Authors:  Ravi Gupta; Vivek Kumar; Kalpana Luthra; Basudeb Banerjee; Manjeet Singh Bhatia
Journal:  J Headache Pain       Date:  2009-01-31       Impact factor: 7.277

8.  A genome-wide association study on androstenone levels in pigs reveals a cluster of candidate genes on chromosome 6.

Authors:  Naomi Duijvesteijn; Egbert F Knol; Jan W M Merks; Richard P M A Crooijmans; Martien A M Groenen; Henk Bovenhuis; Barbara Harlizius
Journal:  BMC Genet       Date:  2010-05-20       Impact factor: 2.797

9.  Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies.

Authors:  Tatiana Rabachini; Helen Trottier; Eduardo L Franco; Luisa L Villa
Journal:  BMC Genet       Date:  2010-05-26       Impact factor: 2.797

10.  The combined effect of SNP-marker and phenotype attributes in genome-wide association studies.

Authors:  E K F Chan; R Hawken; A Reverter
Journal:  Anim Genet       Date:  2008-12-10       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.